preparation of any injectable medicine must be performed by or under direct supervision of a qualified healthcare professional
FormBlends has no affiliation, endorsement, or sponsorship relationship with Eli Lilly, the United States Pharmacopeial Convention, the National Association of Boards of Pharmacy, or any pharmacy or institution referenced in this article
In 2023, the FDA updated its position on bulk drug substances for compounding, and BPC-157 was not included on the list of substances that 503A pharmacies (traditional compounding pharmacies) or 503B outsourcing facilities may use
However, you must disclose all current medications, cognitive enhancers, stimulants, psychiatric medications, and supplements to our physicians during consultation
Injections deliver a full available dose directly into the bloodstream, producing faster results
Time-sensitive US update: FDA briefing documents published in May 2026 proposed that BPC-157 and TB-500-related substances should not be added to the US 503A Bulks List